Invesaro

Stocks YARW Earnings

Earnings

Yarrow Bioscience, Inc. (YARW) earnings

Quarterly results of Yarrow Bioscience, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when YARW files with the SEC.

Next earnings date

Yarrow Bioscience, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Yarrow Bioscience, Inc. reported revenue of $97K (+40.6% on the same quarter a year earlier) and a net loss of $3M.

Diluted earnings per share were -$3.51.

Filed with the SEC on August 13, 2026.

Revenue by quarter
Q1 24: $98K $98K Q1 24Q2 24: $198K $198K Q2 24Q3 24: $121K $121K Q3 24Q4 24: $84K $84K Q4 24Q1 25: $202K $202K Q1 25Q2 25: $69K $69K Q2 25Q1 26: $86K $86K Q1 26Q2 26: $97K $97K Q2 26
Net income by quarter
Q1 24: -$6.2M -$6.2M Q1 24Q2 24: -$9.4M -$9.4M Q2 24Q3 24: -$12.2M -$12.2M Q3 24Q4 24: -$12M -$12M Q4 24Q1 25: -$8.6M -$8.6M Q1 25Q2 25: -$5.8M -$5.8M Q2 25Q1 26: -$3.6M -$3.6M Q1 26Q2 26: -$3M -$3M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$97K+40.6%-$3M-$3.51
Q1 FY2026March 31, 2026$86K-57.4%-$3.6M-$0.08
Q2 FY2025June 30, 2025$69K-65.2%-$5.8M-$6.73
Q1 FY2025March 31, 2025$202K+106.1%-$8.6M-$0.20
Q4 FY2024December 31, 2024$84K--$12M-
Q3 FY2024September 30, 2024$121K--$12.2M-$0.29
Q2 FY2024June 30, 2024$198K--$9.4M-$0.22
Q1 FY2024March 31, 2024$98K--$6.2M-$0.15

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Yarrow Bioscience, Inc.'s next earnings date?

Yarrow Bioscience, Inc. was expected to report around November 5, 2026; nothing is on file with the SEC yet.

What were Yarrow Bioscience, Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, Yarrow Bioscience, Inc. reported revenue of $97K and a net loss of $3M. The figures come from its filing with the SEC.

Is Yarrow Bioscience, Inc.'s revenue growing?

Revenue in Q2 FY2026 was $97K, up 40.6% from $69K in the same quarter a year earlier.

Get an email when YARW reports

Follow YARW and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when YARW files with the SEC.

Source: quarterly figures Yarrow Bioscience, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Yarrow Bioscience, Inc.